Myco-Biosynthesis of Silver Nanoparticles, Optimization, Characterization, and In Silico Anticancer Activities by Molecular Docking Approach against Hepatic and Breast Cancer
Biomolecules · 2024
DOI: 10.3390/biom14091170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Noura El-Ahmady El-Naggar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioprocess Development, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applica…. Hauptthemen laut MEDLINE: Silver, Metal Nanoparticles, Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taif University, Saudi Arabia.
Abstract (Originalsprache)
This study explored the green synthesis of silver nanoparticles (AgNPs) using the extracellular filtrate of Fusarium oxysporum as a reducing agent and evaluated their antitumor potential through in vitro and in silico approaches. The biosynthesis of AgNPs was monitored by visual observation of the color change and confirmed by UV–Vis spectroscopy, revealing a characteristic peak at 418 nm. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) analyses showed spherical nanoparticles ranging from 6.53 to 21.84 nm in size, with stable colloidal behavior and a negative zeta potential of −15.5 mV. Selected area electron diffraction (SAED) confirmed the crystalline nature of the AgNPs, whereas energy-dispersive X-ray (EDX) indicated the presence of elemental silver at 34.35%. A face-centered central composite design (FCCD) was employed to optimize the biosynthesis process, yielding a maximum AgNPs yield of 96.77 µg/mL under the optimized conditions. The antitumor efficacy of AgNPs against MCF-7 and HepG2 cancer cell lines was assessed, with IC50 values of 35.4 µg/mL and 7.6 µg/mL, respectively. Molecular docking revealed interactions between Ag metal and key amino acids of BCL-2 (B-cell lymphoma-2) and FGF19 (fibroblast growth factor 19), consistent with in vitro data. These findings highlight the potential of biologically derived AgNPs as promising therapeutic agents for cancer treatment and demonstrate the utility of these methods for understanding the reaction mechanisms and optimizing nanomaterial synthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioprocess Development, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), New Borg El Arab City 21934, Egypt.
- Botany Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt.
- Department of Biotechnology, College of Science, Taif University, Taif 21944, Saudi Arabia.
- Botany and Microbiology Department, Faculty of Science, Arish University, Al-Arish 45511, Egypt.
ORCID-Profile: Noura El-Ahmady El-Naggar, Hala M Abdelmigid, Amal A Alyamani, Naglaa Elshafey, Yasmin M Heikal
Förderung
- Taif University, Saudi Arabia
Zitieren
APA
El-Naggar, N. E., Shweqa, N. S., Abdelmigid, H. M., Alyamani, A. A., Elshafey, N., Soliman, H. M., & Heikal, Y. M. (2024). Myco-Biosynthesis of Silver Nanoparticles, Optimization, Characterization, and In Silico Anticancer Activities by Molecular Docking Approach against Hepatic and Breast Cancer. Biomolecules. https://doi.org/10.3390/biom14091170
Vancouver
El-Naggar NE, Shweqa NS, Abdelmigid HM, Alyamani AA, Elshafey N, Soliman HM, et al. Myco-Biosynthesis of Silver Nanoparticles, Optimization, Characterization, and In Silico Anticancer Activities by Molecular Docking Approach against Hepatic and Breast Cancer. Biomolecules. 2024. doi:10.3390/biom14091170
BibTeX
@article{ElNaggar2024,
author = {El-Naggar, Noura El-Ahmady and Shweqa, Nada S and Abdelmigid, Hala M and Alyamani, Amal A and Elshafey, Naglaa and Soliman, Hoda M and Heikal, Yasmin M},
title = {Myco-Biosynthesis of Silver Nanoparticles, Optimization, Characterization, and In Silico Anticancer Activities by Molecular Docking Approach against Hepatic and Breast Cancer},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14091170}
}
EUVIMED